Please use this identifier to cite or link to this item:
Title: Narrative discourse therapy for patients in post-traumatic amnesia: a feasibility study.
Epworth Authors: Vazirani, Aashna
Checklin, Martin
McKenzie, Dean
McKay, Adam
Other Authors: Steel, Joanne
Keywords: Post Traumatic Amnesia
Traumatic Brain Injury
Narrative Discourse Therapy
Speech Therapy
Flowerpot Story
Pittsburgh Rehabilitation Participation Scale
The Westmead Post-Traumatic Amnesia Scale
Agitated Behaviour Scale
Feasability Study
Rehabilitation, Mental Health and Chronic Pain Clinical Institute
Issue Date: Oct-2023
Conference Name: Epworth HealthCare Research Month 2023
Conference Location: Epworth Research Institute, Victoria, Australia
Abstract: Development of a treatment protocol targeting narrative discourse skills for people in post-traumatic amnesia following traumatic brain injury. Little is known about the feasibility and potential benefits of providing speech therapy to patients early after traumatic brain injury (TBI), while they are still in post-traumatic amnesia (PTA). In Australia it is often delayed until someone emerges from post-traumatic amnesia (PTA). Recent physiotherapy and occupational studies have found a positive impact on recovery for PTA patients, without increasing agitation. This is an ongoing study but initial results of the first 6 patients found thy were able to sustain and actively participate in therapy sessions targeting narrative course, participation did not lead to agitation, patients gave positive feedback, reported enjoying the therapy and following structured narrative therapy patients in PTA were able to construct a well-rounded story on a self generated/provided topic.
Type: Conference Poster
Affiliated Organisations: University of Newcastle, Newcastle, NSW, Australia.
Type of Clinical Study or Trial: Pilot Study
Appears in Collections:Research Month

Files in This Item:
File Description SizeFormat  
IBIA Poster_Aashna Vazirani.pdf3.56 MBAdobe PDFThumbnail

Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.